世卫组织总干事：中国防控甲型H1N1流感积极有力

5月13日下午，卫生部部长陈竺应约与世界卫生组织（WHO）总干事陈冯富珍通电话。双方围绕甲型H1N1流感防控策略、本次疫情的特点和发展、抗病毒药物和疫苗的研制和储备等交换了看法，     

甲型H1N1流感病原学及其治疗药物和疫苗研究进展

2009年3月下旬以来,墨西哥和美国等国家先后发生甲型H1N1流感爆发流行。6月11日世界卫生组织（WHO）将此次流感全球大流行的预警级别提高到6级。这表明甲型H1N1流感病毒的传染性极强。世界多个实验室已成功分离出甲型H1N1流感病毒,并对其生物学特性做了深入研究;同时为了更好地预防和治疗甲型H1N1流感,为今年秋冬可能发生的第2次甲型H1N1流感大爆发做好更充分的应对准备,全球科学家正加紧研制相关的抗病毒药物和疫苗。为此,对甲型H1N1流感病毒的病原学及其治疗药物和疫苗的研究进展作一综述。     

甲型H1N1流感疫苗临床试验现场组织与实施结果

2009年4月，一种变异的新甲型流感病毒H1N1首先在墨西哥流行，并出现可持续的人际传播，后逐渐传播到美国、加拿大和欧洲、南美洲、大洋洲、亚洲和非洲。世界卫生组织于6月11日将流感大流行的预警级别提高至6级，宣布全球性的流感大流行已经到来。为了及地有效地防控流感大流行，作为防控流感传播最有效的手段之一，甲型H1N1流感疫苗的研制与生产被寄予厚望，疫苗成了最好也是最快捷的解决方法，想提供安全、有效、大数量的疫苗，必须通过全面系统的监床观察，才能为疫苗种类和剂量的选择提供科学依据。     

有甲型H1N1流感疫苗吗？

目前暂没有针对甲型H1N1流感的疫苗。世界卫生组织和国家级专家会根据疫情风险评估，综合考虑启动疫情研制、生产和使用相关事宜。     

世卫：宣布甲型H1N1流感流行结束

8月10日，世界卫生组织宣布甲型H1N1流感大流行已经结束，甲型H1N1病毒的传播基本上接近尾声。     

怀柔区接种甲型H1N1流感疫苗分析

本文对2009年度在怀柔城区的3家预防接种保健科，进行甲型H1N1流感疫苗预防接种的实例分析，与世界卫生组织发布的全球甲型H1N1流感疫苗接种安全性评估结论基本一致，证明我国使用的疫苗安全稳定。     

世界卫生组织称“将确保穷人得到甲型H1N1流感病毒的疫苗”

世界卫生组织说,它正在与疫苗制造商讨论如何确保发展中国家获得用于应对可能的甲型H1N1流感大流行的疫苗供应。有人担心发展中国家将几乎得不到疫苗,因为许多发达国家已经在制药公司那里下了“休眠”订单,一场大流行事件将激活这些订单。     

上海市卢湾区居民甲型H1N1流感及疫苗接种行为调查

目的了解上海市卢湾区居民甲型H1N1流感及疫苗接种相关知识、态度、行为,为今后开展有针对性的干预提供参考。方法采用多阶段单纯随机抽样的方法,在卢湾区4个街道中各随机抽取一个居委并从每个居委随机抽取50人,共调查200人;采用上海市健康教育所统一编制的《上海市防控甲型H1N1流感健康教育调查表》进行调查。结果 62.0%的调查对象对甲型H1N1流感的流行感到担心,97.3%的调查对象认为甲型H1N1流感是可防可控的,大部分调查对象知道感染甲型H1N1流感后的症状并掌握了一些预防流感的措施,81.3%的调查对象知道接种疫苗可以有效预防甲型H1N1流感,32.4%的调查对象已经接种过疫苗,92.9%的调查对象对目前的防控措施感到满意。结论加大健康教育力度,促进居民疫苗接种率,提高居民的公共卫生意识,是防控甲型H1N1流感的有效措施。     

构建全球健康防线——甲型H1N1流感之世卫篇

作为人类健康的卫士，世界卫生组织在此次的甲型H1N1流感疫情的监控过程当中无疑担任着举足轻重的角色。疫情的发展和监控，资源的收集与分配，疫苗的攻坚，每—项都与世界人民的健康紧密相连。世卫组织时刻不忘提醒人们保持警惕，预防第二波疫潮的来临，并为此做出了积极的准备，努力构建全球健康防线。     

云南保山市甲型H1N1流感病毒裂解疫苗应急接种效果分析

目的 了解保山市2009～2010年甲型H1N1流感病例的分布特征及疫苗控制效果,为甲型H1N1流感防控及疫苗的科学使用提供依据.方法 回顾性分析接种疫苗前后保山市甲型H1N1流感发病人群的分布特征,并比较接种前后甲型H1N1流感发生情况.结果 该市总人口接种率为6.26％,其中学生接种率最高为73.44％.甲型H1...     

健康是"1"财富是"0"

越来越多的职业人在越来越多的时间里感到疲劳．或者疲劳成为了日常性的，甚至于连疲劳感都变得模糊了。以此为标志．职业人已经走进了一个多事的过劳时代。     

The "new" medical malpractice crisis--part 1

It is important to put the current medical malpractice crisis into the historical context of the past several decades. Doing so provides an important perspective from which to understand the current iteration. One may reasonably conclude that the present medical malpractice situation is only the latest outbreak of a continuing, chronic condition, rather than a distinct, unusual event. In this regard, it is analogous to a chronic disease that occasionally flares up. Chronicity suggests the presence of major underlying problems, which may be linked to insurance carriers' business cycles as much as reflecting increases in either medical malpractice or the numbers and value of claims. It is useful to bear in mind that the fact of a claim may or may not indicate actual medical malpractice, and increased claims could well correlate more closely with patients' disgruntlement with the medical delivery system, access to it, and the way they were treated by staff than with significant injuries for which compensation should be paid. Regulatory and public policy efforts to date have only affected the problem of medical malpractice at the margin. Apparently, the core of the problem has not been addressed; in fact, it seems as yet to be unidentified. Solutions that focus on the economic dimensions only address the symptoms-claims for medical malpractice-and apparently have done nothing to correct the root cause(s). Part 2 of this two-part series considers and analyzes the current medical malpractice insurance crisis. Its evolution and analysis of specific aspects may provide guidance in understanding how to predict its future course. More important, the analysis will suggest guidance as to how organizations may reduce the potential for the problem and protect themselves from the negative aspects, should it occur.     

"军字一号"工程的实施方案与体会

为探讨医院信息系统的建设和医院管理中的作用，本介绍了“军字一号”工程的实施方案和实施体会；为医院信息系统建设和使用提供参考。     

"军字一号"工程的应用体会

本针对目前军队医院信息化建设发展还不平衡，提出了应重视的问题，即：明确信息化建设的目标；软件开发要有总体规划；重视数据的安全可靠；加强系统的技术维护与人员培训；尽快建立医疗信息的标准。     

"军字一号"工程中护士工作站的运用与管理

护士工作站是“军字一号”工程的重要组成部分，通过对护士工作站相关制度的建立，规范了护士工作站的运行与管理，实现了护士工作站的办公自动化。     

A statistical model for the "N-of-1" study

The controlled clinical trial has largely replaced case-reports as the authoritative source of information concerning the efficacy of treatment. However, many situations arise in clinical practice where treatment decisions cannot be made on the basis of such studies. The definitive clinical trial may not have been performed, or the results from a particular study may not be applicable to a particular patient. Recently, "N-of-1" studies have been proposed for the experimental evaluation of therapy in a single patient. Multiple courses of active and placebo treatments are administered, and efficacy is determined by following the response measure over a period of time. The purpose of this paper is to present a statistical model appropriate for data arising from this design. The model provides for serial correlation among the response measures captured from the subject, and for heteroskedasticity across the treatment periods. ML estimation procedures are considered, and their properties are investigated. A scoring algorithm is described to iterate to the solution of the ML equations, and considerations for hypothesis testing are presented. The techniques are illustrated through an example.